Company Name, Ticker, Customers, else..

Castle Biosciences Inc (CSTL)

Other Ticker:

Sector • Healthcare Industry • Medical Laboratories

Industry • Medical Laboratories

Sector • Healthcare

Castle Biosciences Inc

CSTL's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

CSTL Growth rates comparisons

Looking into Castle Biosciences Inc growth rates, revenue grew by 181.02 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 1348

Medical Laboratories industry recorded deterioration of revenues by -1.94 %

Castle Biosciences Inc realized net income compared to net loss a year ago in IV. Quarter 2022

• More on CSTL's Growth

CSTL's Valuation comparisons

Castle Biosciences Inc
realized net loss in trailing twelve months.

Castle Biosciences Inc realized cash outflow of $ -7.94per share in trailing twelve-month period.

Company

-

PE TTM

Industry

19.5

PE TTM

Company's Price to Sales ratio is at 4.14.
Medical Laboratories industry's Price to Sales ratio is at 2.1.

• More on CSTL's Valuation

Total Debt (Millions $)	-
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	6.27
Tangible Book Value (Per Share $)	10.48

CSTL's Valuation comparisons

Castle Biosciences Inc
realized net loss in trailing twelve months.

Castle Biosciences Inc realized cash outflow of $ -7.94per share in trailing twelve-month period.

Company

-

PE TTM

Industry

19.5

PE TTM

Company's Price to Sales ratio is at 4.14.
Medical Laboratories industry's Price to Sales ratio is at 2.1.

Castle Biosciences Inc Price to Book Ratio is at 1.44 lower than Indusry Avg. of 351.07. and higher than S&P 500 Avg. of -0.01

• More on CSTL's Valuation

• Market Capitalization (Millions $)	577
• Shares Outstanding (Millions)	26
• Employees	-
• Revenues (TTM) (Millions $)	139
• Net Income (TTM) (Millions $)	43
• Cash Flow (TTM) (Millions $)	-207
• Capital Exp. (TTM) (Millions $)	-6
• Total Debt (Millions $)	-
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	6.27
• Tangible Book Value (Per Share $)	10.48

• Market Capitalization (Millions $)	577
• Shares Outstanding (Millions)	26
• Employees	-
• Revenues (TTM) (Millions $)	139
• Net Income (TTM) (Millions $)	43
• Cash Flow (TTM) (Millions $)	-207
• Capital Exp. (TTM) (Millions $)	-6

	*Ratio*
• Capital Ratio (MRQ)	8.09
• Total Debt to Equity (MRQ)	-
• Tangible Leverage Ratio (MRQ)	0.13
• Asset Turnover Ratio (TTM)	0.31
• Inventory Turnover Ratio (TTM)	9.75

CSTL's Profitability Comparisons

Castle Biosciences Inc net profit margin of 39.85 % is currently ranking no. 2 in Medical Laboratories industry, ranking no. 30 in Healthcare sector and number 253 in S&P 500.

• More on CSTL's Key Ratios


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar FDBC's Profile Stock Price FDBC's Financials Business Description Fundamentals Charts & Quotes FDBC's News Suppliers FDBC's Competitors Customers & Markets Economic Indicators FDBC's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071